Joe Miller
Joe Miller is a journalist and writer based in Frankfurt, Germany.
As the Financial Times' correspondent, he closely followed BioNTech's COVID-19 vaccine development in real-time.
Miller's reporting focuses on German business, technology, and innovation.
His background in business journalism is evident in the book's emphasis on the financial and corporate aspects of vaccine development.
Some readers noted that while Miller's business acumen shines through, his science writing occasionally lacks the precision of a specialized science writer.
Nevertheless, his insider access and contemporaneous reporting provided a unique perspective on one of the most significant scientific achievements of recent times.
